HTG Molecular Diagnostics, Inc. (HTGMQ)

HTG Molecular Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	4	38	22	27	70
Market Cap Growth	-	-90.56%	69.59%	-17.12%	-61.74%	212.65%
Enterprise Value	-	-4	40	12	30	71
PE Ratio	-	-0.16	-2.19	-1.06	-1.39	-4.25
PS Ratio	0.00	0.56	4.22	2.59	1.39	3.25
PB Ratio	0	0.66	3.61	1.53	1.12	3.31
P/FCF Ratio	-	-0.19	-2.19	-1.32	-1.50	-4.95
P/OCF Ratio	-	-0.19	-2.28	-1.36	-1.60	-5.31
EV/Sales Ratio	-	-0.60	4.46	1.45	1.58	3.31
EV/EBITDA Ratio	-	0.19	-2.03	-0.69	-1.83	-5.09
EV/EBIT Ratio	-	0.18	-1.96	-0.64	-1.66	-4.61
EV/FCF Ratio	-	0.21	-2.31	-0.74	-1.71	-5.04
Debt / Equity Ratio	0	0.90	1.13	0.87	0.47	0.62
Debt / EBITDA Ratio	-	-0.24	-0.60	-0.70	-0.68	-0.69
Debt / FCF Ratio	-	-0.26	-0.68	-0.76	-0.63	-0.69
Quick Ratio	0	1.65	2.42	4.19	4.07	5.15
Current Ratio	0	1.89	2.73	4.54	4.65	5.42
Asset Turnover	0.23	0.36	0.29	0.24	0.43	0.49
Interest Coverage	0	-24.31	-16.74	-19.11	-19.80	-17.92
Return on Equity (ROE)	-	-400.51%	-164.86%	-144.08%	-80.51%	-78.01%
Return on Assets (ROA)	-	-121.47%	-56.29%	-59.29%	-42.77%	-37.59%
Return on Capital (ROIC)	-	-203.70%	-80.62%	-72.19%	-53.83%	-52.51%
Earnings Yield	-293507.14%	-608.60%	-45.61%	-94.15%	-72.15%	-23.54%
FCF Yield	-192503.04%	-519.44%	-45.63%	-75.54%	-66.55%	-20.20%
Buyback Yield / Dilution	-53.85%	-49.88%	-82.20%	-38.43%	-159.72%
Total Shareholder Return	-53.85%	-49.88%	-82.20%	-38.43%	-159.72%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.